Presence / absence determination device

The presence/absence determination device uses ballistocardial motion signals to enhance accuracy by setting thresholds and determination times, addressing issues with pressure sensors in detecting user presence or absence, especially with low weights and cushion interference.

JP7594533B2Active Publication Date: 2024-12-04SUMITOMO RIKO CO LTD
View PDF 4 Cites 0 Cited by

Patent Information

Application Number
JP2021542674
Authority / Receiving Office
JP · JP
Patent Type
Patents
Current Assignee / Owner
Priority Date
2019-08-30
Filing Date
2020-07-31
Publication Date
2024-12-04
Estimated Expiration
2040-07-31

AI Technical Summary

Technical Problem

Existing presence/absence determination devices using pressure sensors face accuracy issues when the user's weight is light, are affected by cushions, and can make erroneous determinations due to temporary changes in pressure, such as when a user turns over or sits up.

Method used

A presence/absence determination device utilizing a flexible piezoelectric sensor that detects ballistocardial motion signals, including a ballistocardial signal acquisition unit, an absence determination unit, and a presence determination unit, which set thresholds and determination times to accurately identify the presence or absence of a user based on ballistocardial signals.

Benefits of technology

The device provides accurate presence/absence determinations by minimizing errors from temporary pressure changes and external vibrations, ensuring reliable detection even with low user weight or cushion interference.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 0007594533000001
    Figure 0007594533000001
  • Figure 0007594533000002
    Figure 0007594533000002
  • Figure 0007594533000003
    Figure 0007594533000003
Patent Text Reader

Abstract

Provided is a novel presence determination device whereby presence in a detection region of a user can be determined with excellent precision. A presence determination device 10 for determining whether an organism A is present in a detection region 36, wherein the presence determination device 10 has a flexible piezoelectric sensor sheet 12 which is laid in the detection region 36 and which outputs a detection signal corresponding to an input vibration, a ballistic heart motion signal acquisition unit 40 for extracting a ballistic heart motion signal corresponding to ballistic heart motion from a detection signal of the piezoelectric sensor sheet 12, and an absence determination unit 44 for making an absence determination which indicates that the organism A is not present in the detection region 36 on the basis of the ballistic heart motion signal, the absence determination unit 44 making an absence determination when a state in which the ballistic heart motion signal is less than an absence threshold value α continues for more than an absence determination time.
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] The present invention relates to a presence / absence determining device for determining whether or not a living organism is present in a detection area. [Background technology]

[0002] For example, in medical or nursing care settings, it may be necessary to determine whether a patient (someone requiring assistance) is in bed, or to determine whether there are any vacant seats in places with many seats, such as restaurants, movie theaters, and trains, and to determine whether a person is present in a specific area without requiring the effort of human confirmation.

[0003] In addition, for example, when judging the quality of sleep, it is effective to measure the number of times and the time for which a person gets up and leaves bed during the night.

[0004] Therefore, a presence / absence determination device has been proposed that uses a pressure sensor to determine whether or not a person is present on a detection area such as a bed or a chair seat based on the pressure detection result. For example, in JP 2015-8920 A (Patent Document 1), a pressure sensor is provided on bedding, and the presence / absence of a user on the bedding is determined based on the user's body load (body pressure) detected by the pressure sensor. [Prior art documents] [Patent documents]

[0005] [Patent Document 1] JP 2015-8920 A Summary of the Invention [Problem to be solved by the invention]

[0006] However, when a user such as a patient is light in weight, there is a risk that the detection accuracy of the pressure sensor may decrease.

[0007] Furthermore, when a cushion such as a bed pad or a seat cushion is present between the pressure sensor and the user, the accuracy of pressure detection is also reduced.

[0008] Furthermore, if the pressure acting on the pressure sensor is temporarily reduced or released during bodily movements such as turning over or sitting upright, it may result in a false determination that the user is no longer present, or a false determination that the user has made a bodily movement such as turning over or sitting upright when the user is no longer present.

[0009] An object of the present invention is to provide a novel presence / absence determining device that can improve at least one of the above-mentioned problems and determine with high accuracy the presence / absence of a user in a detection area. [Means for solving the problem]

[0010] The following describes preferred embodiments for understanding the present invention, but the embodiments described below are merely illustrative and may be combined with one another as appropriate, and the multiple components described in each embodiment may be recognized and used independently as far as possible, and may also be combined with any of the components described in another embodiment as appropriate. As a result, the present invention is not limited to the embodiments described below, and various other embodiments may be realized.

[0011] The first aspect is a presence / absence determination device that determines whether or not a living organism is present on a detection area, and includes a flexible piezoelectric sensor sheet that is laid in the detection area and outputs a detection signal corresponding to an input vibration, a ballistocardiogram signal acquisition unit that extracts a ballistocardiogram signal corresponding to the ballistocardiogram from the detection signal of the piezoelectric sensor sheet, and an absence determination unit that performs an absence determination that the living organism is not present on the detection area based on the ballistocardiogram signal, and the absence determination unit performs the absence determination when the state in which the ballistocardiogram signal is below an absence threshold continues beyond an absence determination time. and a presence determination unit that performs a presence determination of the presence of the living body on the detection area based on the ballistocardiogram signal, the presence determination unit performs the presence determination when the state in which the ballistocardiogram signal exceeds a presence threshold continues beyond a presence determination time, and the presence determination unit has a body movement determination unit that performs a body movement determination that determines the body movement of the living body on the detection area based on the ballistocardiogram signal, and the body movement threshold used for the body movement determination in the body movement determination unit is set to a value greater than the presence threshold, and when the value of the ballistocardiogram signal exceeds the body movement threshold and the presence determination unit detects the presence of the living body and performs the presence determination for a predetermined time before and after the value of the ballistocardiogram signal exceeds the body movement threshold, the body movement determination unit detects the body movement of the living body and performs the body movement determination. It is something.

[0012] According to the presence / absence determining device of this aspect, by determining the absence / presence based on ballistocardiogram, it is possible to make a more accurate determination than a determination based on pressure due to the body weight or the like of a living body.

[0013] In addition, with regard to determining whether a patient is absent, such as when the patient leaves the bed, which can be a problem when monitoring a patient, a more accurate determination can be made by setting an absence determination time rather than immediately determining that the patient is absent when the amplitude of the vibration input to the piezoelectric sensor sheet becomes smaller simply because the patient turns over in bed and this causes a change in posture. Furthermore, in the presence determination, even if the vibration level temporarily increases due to external vibration noise or the like, it will not be erroneously determined that the object is immediately present, allowing for a more accurate determination. In addition, it can detect body movements such as turning over in a lying position or shifting in a sitting position more accurately. In a second aspect, in the presence / absence determining device according to the first aspect, the presence determination time is set within a range of 0.5 seconds to 30 seconds. According to the presence / absence determination device of this aspect, accurate determination is possible by setting the presence determination time within the above range. That is, if the presence determination time is too short, there is a risk that an erroneous presence determination will be made due to external vibrations, etc. Also, if the presence determination time is too long, there is a risk that the presence determination will not be made correctly when the object is in the detection area for only a short time. In a third aspect, in the presence / absence determining device of the first or second aspect, the presence determining unit performs the presence determination by comparing a representative value of the ballistocardiogram signal within a specified time period with the presence threshold value. According to the presence / absence determining device of this aspect, by adopting a representative value according to the purpose, it is possible to determine the presence / absence with high accuracy, reduce erroneous determinations due to noise, and simplify the calculation process for determining the presence / absence. In a fourth aspect, in the presence / absence determination device of the first or second aspect, the presence determination unit performs the presence determination by comparing any one of the maximum value, minimum value, average value, median value, or sum of the ballistocardiogram signal within a specified period of time with a presence threshold value. According to the presence / absence determination device of this aspect, for example, by adopting the maximum value of the ballistocardiogram signal within a predetermined time as a value to be compared with the presence threshold, the maximum amplitude of the ballistocardiogram waveform can be obtained easily, and the presence / absence can be determined with high accuracy. Also, by adopting the minimum value, average value, or median value of the ballistocardiogram signal within a predetermined time, it becomes difficult to erroneously determine the presence of a subject when it is not present due to noise. Alternatively, by adopting the sum of the ballistocardiogram signal, the calculation process for determining the presence of a subject becomes simple, thereby reducing the load. A fifth aspect is the presence / absence determining device according to any one of the first to fourth aspects, wherein the presence threshold and the absence threshold are set independently as different values ​​from each other. According to the presence / absence determining device of this aspect, presence / absence can be determined with greater accuracy. A sixth aspect is the presence / absence determining device according to the fifth aspect, wherein the presence threshold is three times or more the absence threshold. According to the presence / absence determining device of this aspect, presence / absence can be determined with even greater accuracy. A seventh aspect is a presence / absence determination device relating to any one of the first to sixth aspects, which is provided with a vital frequency analysis unit that performs frequency analysis on the detection signal of the piezoelectric sensor sheet to calculate a vital spectrum including a power spectrum resulting from ballistocardiogram of the living body, and the ballistocardiogram signal acquisition unit acquires the ballistocardiogram signal based on the vital spectrum. According to the presence / absence determining device of this aspect, even when the amplitude of the vibration input to the piezoelectric sensor sheet is small and the detection signal is weak, it is possible to perform a highly accurate presence / absence determination based on the frequency analysis result of the detection signal. Therefore, even when the amplitude of the input to the piezoelectric sensor sheet is small, for example, because the piezoelectric sensor sheet is laid under a mattress, it is possible to accurately determine the presence / absence of a user. An eighth aspect is a presence / absence determination device for determining whether or not a living organism is present on a detection area, the presence / absence determination device having a flexible piezoelectric sensor sheet laid in the detection area and outputting a detection signal corresponding to an input vibration, a ballistocardiogram signal acquisition unit for extracting a ballistocardiogram signal corresponding to the ballistocardiogram from the detection signal of the piezoelectric sensor sheet, and an absence determination unit for performing an absence determination that the living organism is not present on the detection area based on the ballistocardiogram signal, and the absence determination unit performs the absence determination when the state in which the ballistocardiogram signal is below an absence threshold continues beyond an absence determination time, and the detection signal of the piezoelectric sensor sheet is frequency-analyzed to determine the cardiogram of the living organism. The device is equipped with a vital frequency analysis unit that calculates a vital spectrum including a power spectrum caused by ballistic motion, and the ballistocardiogram signal acquisition unit acquires the ballistocardiogram signal based on the vital spectrum, and is equipped with a noise frequency analysis unit that frequency analyzes the detection signal of the piezoelectric sensor sheet to calculate a noise spectrum, which is a power spectrum in a higher frequency range than the vital frequency range, which is the frequency range of the vital spectrum, and the absence determination by the absence determination unit is performed by comparing the S / N ratio, which is the ratio of the ballistocardiogram signal to the noise signal based on the noise spectrum, with the absence threshold value. According to the presence / absence determining device of this aspect, by determining the absence / presence based on ballistocardiogram, it is possible to make a more accurate determination than a determination based on pressure due to the body weight or the like of a living body. In addition, with regard to determining whether a patient is absent, such as when the patient leaves the bed, which can be a problem when monitoring a patient, a more accurate determination can be made by setting an absence determination time rather than immediately determining that the patient is absent when the amplitude of the vibration input to the piezoelectric sensor sheet becomes smaller simply because the patient turns over in bed and this causes a change in posture. Furthermore, even if the amplitude of the vibration input to the piezoelectric sensor sheet is small and the detection signal is weak, it is possible to determine the presence or absence with high accuracy based on the frequency analysis results of the detection signal. Therefore, even if the amplitude of the input to the piezoelectric sensor sheet is small, for example, because the piezoelectric sensor sheet is placed under a mattress, it is possible to accurately determine the presence or absence of a user. In addition, by determining the presence or absence by comparing the S / N ratio, which is the ratio of the ballistocardiogram signal to the noise signal, with an absence threshold, it becomes less likely that an erroneous determination will occur in which, for example, the power spectrum of the vital frequency range is boosted by white noise and a presence is mistakenly determined when a presence is not present. Preferably, the noise signal is acquired based on a representative value of the noise spectrum. The representative value of the noise spectrum is appropriately selected from, for example, the maximum value, minimum value, average value, median value, summation, etc. of the noise spectrum. By adopting a representative value according to the purpose, it is possible to achieve highly accurate determination of the presence or absence, reduce erroneous determination due to noise, and simplify the calculation process for the presence or absence determination. A ninth aspect is a presence / absence determination device according to the seventh or eighth aspect, wherein the vital spectrum is a power spectrum having both a ballistocardiogram spectrum, which is a power spectrum resulting from the ballistocardiogram of the living body, and a respiratory spectrum, which is a power spectrum resulting from the breathing of the living body. According to the present embodiment of the presence / absence determination device, the vital spectrum includes a respiratory spectrum that is larger than the ballistocardiogram spectrum, so that the vital spectrum can be obtained larger. Therefore, even if the detection signal is weak, the ballistocardiogram signal obtained based on the vital spectrum can be obtained stronger, and the presence / absence determination can be performed with high accuracy. A tenth aspect is the presence determining device according to any one of the seventh to ninth aspects, wherein the ballistocardiogram signal is acquired based on a representative value of the vital spectrum. According to the presence / absence determining device of this aspect, by adopting a representative value according to the purpose, it is possible to determine the presence / absence with high accuracy, reduce erroneous determinations due to noise, and simplify the calculation process for determining the presence / absence. An eleventh aspect is the presence / absence determination device of the tenth aspect, wherein the representative value of the vital spectrum is any one of the maximum value, minimum value, average value, median value, or sum of the vital spectrum. According to the presence / absence determination device of this aspect, for example, by adopting a ballistocardiogram signal based on the maximum value of the vital spectrum as a value to be compared with the absence threshold, the presence / absence can be determined with high accuracy. Also, by adopting a ballistocardiogram signal based on the minimum value, average value, or median value of the vital spectrum, it becomes difficult to erroneously determine that the subject is present due to noise when the subject is absent. Alternatively, by adopting a ballistocardiogram signal based on the sum of the vital spectrum, the calculation process for determining the absence can be simplified, thereby reducing the load. A twelfth aspect is the presence / absence determining device according to any one of the seventh to eleventh aspects, wherein the piezoelectric sensor sheet is disposed under a cushion body on which the living body is placed. According to the presence / absence determining device of this aspect, the cushion body on the piezoelectric sensor sheet prevents the piezoelectric sensor sheet from shifting or deforming due to the user's body movements. In addition, because the upper surface of the piezoelectric sensor sheet is covered with the cushion body, even if a highly sensitive piezoelectric sensor sheet is used, the detection signal is less susceptible to the effects of wind, etc.

[0014] No. Thirteen The first aspect is ~ Any one of the twelfth In the presence / absence determining device according to the aspect, the absence determining time is set within a range of 0.5 seconds to 60 seconds.

[0015] According to the presence / absence determination device of this aspect, accurate determination is possible by setting the non-existence determination time within the above range. That is, if the non-existence determination time is too short, there is a risk of erroneous determination occurring when the level of the ballistocardiogram signal temporarily drops due to erroneous detection or the like. Also, if the non-existence determination time is too long, there is a risk of non-existence determination not being performed even if the subject leaves the detection area once and then returns.

[0016] No. Fourteen The first aspect is ~ Any one of the thirteen In the presence / absence determining device according to the aspect of the present invention, the absence determining unit performs the absence determination by comparing a representative value of the ballistocardiogram signal within a predetermined time period with the absence threshold value.

[0017] According to the presence / absence determining device of this aspect, by adopting a representative value according to the purpose, it is possible to determine the presence / absence with high accuracy, reduce erroneous determinations due to noise, and simplify the calculation process for determining the presence / absence.

[0018] No. Fifteen The first aspect is ~ Any one of the thirteen In the presence / absence determination device of this aspect, the absence determination unit makes the absence determination by comparing any one of the maximum value, minimum value, average value, median value, and sum of the ballistocardiogram signal within a specified period of time with the absence threshold value.

[0019] According to the presence / absence determination device of this aspect, for example, by adopting the maximum value of the ballistocardiogram signal within a predetermined time as a value to be compared with the absence threshold, the maximum amplitude of the heartbeat waveform can be obtained easily, and the presence / absence can be determined with high accuracy. Also, by adopting the minimum value, average value, or median value of the ballistocardiogram signal within a predetermined time, it becomes difficult to erroneously determine the presence of the object when it is not present due to noise. Alternatively, by adopting the sum of the ballistocardiogram signal, the calculation process for the absence determination becomes simple, thereby reducing the load.

[0020]

[0021]

[0022]

[0023]

[0024]

[0025]

[0026]

[0027]

[0028]

[0029]

[0030]

[0031]

[0032]

[0033]

[0034] No. sixteen The above first to fourth aspects are Fifteen In the presence / absence determining device according to any one of the above aspects, a signal amplifier unit is provided which amplifies the ballistocardiogram signal.

[0035] According to the presence / absence determining device of this aspect, the presence determination and the absence determination are performed based on the ballistocardiogram signal amplified by the signal amplifier, thereby improving the determination accuracy.

[0036] No. seventeen The embodiment of the present invention is sixteen In the presence / absence determining device according to the aspect, a heartbeat waveform calculation unit is provided which calculates a heartbeat waveform from the ballistocardiogram signal amplified by the signal amplification unit.

[0037] According to the presence / absence determination device of this aspect, when performing non-presence determination based on a ballistocardiogram signal, it is possible to suppress the influence of noise, etc., and improve the determination accuracy by making the determination using a heartbeat waveform obtained from the ballistocardiogram signal, rather than directly using the ballistocardiogram signal. In addition, for example, the heartbeat waveform can be displayed on a monitor, and the presence / absence of the user can be determined based on the presence or absence of the heartbeat waveform displayed on the monitor.

[0038]

[0039]

[0040]

[0041]

[0042]

[0043]

[0044]

[0045]

[0046]

[0047]

[0048]

[0049]

[0050] Effect of the Invention

[0051] According to the presence / absence determining device of the present invention, by providing an absence determination time, it is possible to more accurately determine whether or not a living organism is present in the detection area. [Brief description of the drawings]

[0052] [Figure 1] FIG. 1 is an explanatory diagram for explaining a presence / absence determining device according to a first embodiment of the present invention; [Diagram 2] FIG. 2 is an explanatory diagram for explaining a piezoelectric sensor sheet constituting the presence / absence determining device shown in FIG. 1; [Diagram 3] FIG. 3 is a plan view showing a sensor body constituting the piezoelectric sensor sheet shown in FIG. 2. [Figure 4] IV-IV cross section in FIG. [Diagram 5] Graph showing a specific example of a vibration waveform including ballistocardiogram acquired by a piezoelectric sensor sheet [Figure 6] 6 is a graph showing the waveform of the ballistocardiogram component extracted from the vibration waveform shown in FIG. 5. [Figure 7] 7 is a graph showing the waveform shown in FIG. 6 after the signal is amplified by a signal amplifier. [Figure 8] Graphs showing exemplary ballistocardiogram signals used to explain the presence or absence of each of the conditions (i) to (v) [Figure 9] A graph showing the waveform of the heart rate component extracted from the amplified signal shown in FIG. [Figure 10] FIG. 11 is an explanatory diagram for explaining a presence / absence determining device according to a second embodiment of the present invention; [Figure 11] Graph showing a specific example of a vibration waveform including ballistocardiogram acquired by a piezoelectric sensor sheet [Figure 12] Flowchart of presence / absence determination in the presence / absence determining device shown in FIG. [Figure 13] 12 is a graph showing an enlarged time period T1 in which the user is determined to be getting out of bed in the vibration waveform shown in FIG. [Figure 14] A graph of the power spectrum calculated by frequency analysis of the vibration waveform shown in Figure 13. [Figure 15]12 is a graph showing an enlarged time period T2 in which the patient is determined to be in bed while breathing has stopped in the vibration waveform shown in FIG. [Figure 16] A graph of the power spectrum calculated by frequency analysis of the vibration waveform shown in Figure 15. [Figure 17] 12 is an enlarged graph showing a time period T3 during which the patient is determined to be in bed while breathing in the vibration waveform shown in FIG. [Figure 18] A graph of the power spectrum calculated by frequency analysis of the vibration waveform shown in Figure 17. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0053] In order to clarify the present invention more specifically, embodiments of the present invention will be described in detail below with reference to the drawings.

[0054] 1 shows a presence / absence determining device 10 according to a first embodiment of the present invention. This presence / absence determining device 10 includes a piezoelectric sensor sheet 12 that receives minute body movements of a living body of a user A, such as breathing and heartbeat, and relatively large body movements, such as turning over in bed, and outputs detection signals corresponding to the input body movements (vibrations), and an analyzer 14 that analyzes the detection signals output from the piezoelectric sensor sheet 12.

[0055] More specifically, the piezoelectric sensor sheet 12 has a structure as shown in Fig. 2, for example, and includes a generally rectangular sheet-like flexible sensor body 16. As shown in Figs. 3 and 4, the sensor body 16 includes a piezoelectric layer 18, a pair of electrode layers 20a, 20b, and a pair of protective layers 22a, 22b.

[0056] The piezoelectric layer 18 may be made of ceramics, synthetic resin, rubber elastic body (including elastomer), etc., but in this embodiment, it is made of a rubber elastic body. The rubber elastic body used as the material of the piezoelectric layer 18 is preferably one or more selected from crosslinked rubber and thermoplastic elastomer, such as urethane rubber, silicone rubber, nitrile rubber (NBR), hydrogenated nitrile rubber (H-NBR), acrylic rubber, natural rubber, isoprene rubber, ethylene-propylene-diene rubber (EPDM), ethylene-vinyl acetate copolymer, ethylene-vinyl acetate-acrylic acid ester copolymer, butyl rubber, styrene-butadiene rubber, fluororubber, epichlorohydrin rubber, etc. Also, an elastomer modified by introducing a functional group, etc. may be used. As the modified elastomer, hydrogenated nitrile rubber having one or more selected from a carboxyl group, a hydroxyl group, and an amino group is preferable.

[0057] The piezoelectric layer 18 also contains piezoelectric particles. The piezoelectric particles are particles of a compound having piezoelectricity. Ferroelectrics having a perovskite crystal structure are known as compounds having piezoelectricity, and one or a mixture of two or more of barium titanate, strontium titanate, potassium niobate, sodium niobate, lithium niobate, potassium sodium niobate, potassium sodium lithium niobate, lead zirconate titanate (PZT), barium strontium titanate (BST), bismuth lanthanum titanate (BLT), and bismuth strontium tantalate (SBT) can be suitably used.

[0058] The electrode layers 20a, 20b preferably have flexibility that allows them to deform in accordance with the piezoelectric layer 18. Such electrode layers 20a, 20b can be formed from, for example, a conductive material in which a conductive material is mixed with a binder, conductive fibers, etc. As the binder, the same materials as the crosslinked rubber and thermoplastic elastomer constituting the piezoelectric layer 18 described above can be used.

[0059] In addition, the conductive material to be mixed into the electrode layers 20a, 20b is not limited, but may be appropriately selected from metal particles made of silver, gold, copper, nickel, rhodium, palladium, chromium, titanium, platinum, iron, and alloys thereof, metal oxide particles made of zinc oxide, titanium oxide, and the like, metal carbide particles made of titanium carbonate, and the like, metal nanowires made of silver, gold, copper, platinum, nickel, and the like, carbon black, carbon nanotubes, graphite, thin-layer graphite, graphene, and other conductive carbon materials.

[0060] As the material for the protective layers 22a and 22b, the same materials as the crosslinked rubber and thermoplastic elastomer constituting the piezoelectric layer 18 described above can be used.

[0061] In this embodiment, the piezoelectric layer 18, the electrode layers 20a, 20b, and the protective layers 22a, 22b are all formed in a thin rectangular plate shape, and the electrode layers 20a, 20b are fixed to both sides of the piezoelectric layer 18 in the thickness direction, and the protective layers 22a, 22b are fixed to both sides of the piezoelectric layer 18 and the electrode layers 20a, 20b in the thickness direction. As a result, the piezoelectric layer 18 and the electrode layers 20a, 20b are embedded inside the protective layers 22a, 22b without being exposed to the outside. With this structure, the sensor body 16 is formed in a thin, approximately rectangular sheet shape.

[0062] In the widthwise central portion of the sensor body 16, the area where the piezoelectric layer 18 and the electrode layers 20a, 20b overlap in the thickness direction is designated as a pressure-sensitive portion 24, and an electric charge is generated when a load is applied to the pressure-sensitive portion 24.

[0063] In addition, the piezoelectric sensor sheet 12 of this embodiment is equipped with a controller 26 and a connector 28, and the electrode layers 20a, 20b and the controller 26 are electrically connected by wiring 30a, 30b, and the controller 26 is electrically connected to the analysis device 14 via the connector 28.

[0064] The controller 26 has, for example, an amplifier and an A / D converter. The amplifier amplifies the output (voltage) of the piezoelectric sensor sheet 12. The A / D converter converts the output amplified by the amplifier from an analog signal to a digital signal. However, the output of the piezoelectric sensor sheet 12 may be amplified by the amplifier after being converted from an analog signal to a digital signal by the A / D converter.

[0065] The analysis device 14 only needs to be capable of calculating the signal controlled by the controller 26 (i.e., the digital signal converted by the A / D conversion unit), and can be realized, for example, by a computer including a monitor unit 32 and a computer program installed on the computer to perform operation.

[0066] Here, in this embodiment, the piezoelectric sensor sheet 12 is laid so as to extend in the width direction of the bed 36 as the detection area on which the user A lies. In particular, in this embodiment, the piezoelectric sensor sheet 12 has a belt part 38 whose length is adjustable, and the belt part 38 is wrapped around the mattress of the bed 36 to fix the piezoelectric sensor sheet 12 on the mattress, and a sheet is placed over the mattress on which the piezoelectric sensor sheet 12 is fixed. As a result, the user A lies on the piezoelectric sensor sheet 12 without directly contacting the piezoelectric sensor sheet 12, and in this embodiment, the piezoelectric sensor sheet 12 is provided near the chest of the user A. This makes it easier to obtain the ballistocardiogram of the user A even if the user A's posture changes slightly, for example, by turning over in bed.

[0067] When small or large body movements (vibrations) in a broad sense are input to the pressure-sensitive portion 24 of the piezoelectric sensor sheet 12 due to breathing, heartbeat, turning over, etc. of the user A, an electric charge is generated in the piezoelectric layer 18, and the generated electric charge is detected by the controller 26 as a change in voltage or current. A specific example of the relationship between the electric charge (signal) detected by the controller 26 and time is shown in the graph of FIG. 5. That is, the detection signal shown in the graph of FIG. 5 is derived from body movements in a broad sense, such as breathing, heartbeat, turning over, etc. Note that the detection signal shown in FIG. 5 is raw data that has not been processed or corrected.

[0068] Hereinafter, a specific example of a procedure for determining whether or not user A is present on the bed 36 based on the ballistocardiogram of user A using the presence determining device 10 will be described.

[0069] First, the charge (signal) generated in the piezoelectric layer 18 is detected through a high-pass filter (ballistocardiogram filter) that cuts off frequency components below 4 Hz (passes frequency components of 4 Hz or higher). In other words, generally, the heartbeat is a vibration of about 1 Hz, but ballistocardiogram (body vibration caused by the heartbeat) is a vibration of 4 Hz or higher, and by using a high-pass filter that passes frequency components of 4 Hz or higher or a band-pass filter that passes frequency components of 4 Hz to 20 Hz, the component of body movement (ballistocardiogram) caused by the heartbeat is extracted from body movements in a broad sense caused by breathing, heartbeat, turning over in bed, etc. FIG. 6 shows the waveform at the time when only the component derived from the ballistocardiogram is extracted after passing through the high-pass filter (or band-pass filter).

[0070] Next, a squaring operation is performed to square and amplify the signal value obtained through a high-pass filter that transmits frequency components of 4 Hz or more (or a band-pass filter that transmits frequency components of 4 Hz to 20 Hz). As a result, the value on the vertical axis of the graph in Figure 6 is squared, emphasizing the peak of the ballistocardial vibration. Figure 7 shows a waveform in which such ballistocardial vibration has been emphasized.

[0071] The high-pass filter or band-pass filter is provided, for example, in the controller 26 of the piezoelectric sensor sheet 12, and a ballistocardiogram signal at a desired frequency is acquired. Therefore, a ballistocardiogram signal acquisition unit 40 that extracts a ballistocardiogram signal corresponding to the ballistocardiogram from the detection signal of the piezoelectric sensor sheet 12 may be provided in the controller 26. The ballistocardiogram signal converted into a digital signal by the A / D conversion unit may then be transmitted to the computer of the analysis device 14, and subsequent calculations may be performed on the computer. The signal amplification unit 42 that amplifies the ballistocardiogram signal may be provided in the controller 26, or may be configured to include the computer of the analysis device 14 and a program installed on the computer.

[0072] Here, a representative value within a predetermined time period is calculated from the ballistocardiogram signal (FIG. 7) that has been squared and emphasized. As this representative value, for example, any one of the maximum value, minimum value, average value, median value, and sum within the predetermined time period is adopted. In this embodiment, the average value for the previous 0.1 seconds is calculated. In the following description, the representative value of the ballistocardiogram signal is simply described as the ballistocardiogram signal.

[0073] In Fig. 8, as a specific example, the ballistocardiogram signal of the user A is measured for a predetermined time, and a representative value calculated from the ballistocardiogram signal is shown as an example. Note that Fig. 8 is a graph for simply explaining the states (i) to (v) described below, and the values ​​on the vertical and horizontal axes in the graph are not accurate. In addition, in this embodiment, an absence threshold α, a presence threshold β, and a body movement threshold γ to be compared with the ballistocardiogram signal are set in advance. Then, the state of the user A on the bed 36 is determined according to the magnitude relationship between the ballistocardiogram signal and the absence threshold α, the presence threshold β, and the body movement threshold γ, and the duration of the magnitude relationship.

[0074] That is, if the state in which the ballistocardiogram signal is below the absence threshold α continues beyond the absence determination time, it is determined that the user A is not present (absent) on the bed 36. In this embodiment, the absence threshold α is set to 20 [digits]. Note that a digit is the smallest display unit of a digital measuring device.

[0075] Moreover, the absence determination time is preferably set to 0.5 seconds or more. If the absence determination time is shorter than 0.5 seconds, there is a risk that the absence will be erroneously determined when the level of the ballistocardiogram signal temporarily drops due to a change in posture, erroneous detection, or the like. Furthermore, the absence determination time is preferably set to 60 seconds or less. If the absence determination time is longer than 60 seconds, there is a risk that the absence will not be determined when, for example, the person temporarily leaves the bed 36. It is more preferable that the absence determination time is set within a range of 5 seconds to 45 seconds, and in this embodiment, it is set to 20 seconds.

[0076] Furthermore, if the state in which the ballistocardiogram signal exceeds the presence threshold value β continues beyond the presence determination time, it is determined that the user A is present on the bed 36. This presence threshold value β may be the same value as the absence threshold value α, but it is preferable that the presence threshold value β and the absence threshold value α are different values ​​that are independent of each other. In addition, it is preferable that the presence threshold value β is three times or more the absence threshold value α, and in this embodiment, the presence threshold value β is set to 100 [digits].

[0077] Furthermore, the presence determination time is preferably set to 0.5 seconds or more. If the presence determination time is shorter than 0.5 seconds, there is a risk that the presence will be erroneously determined when vibration is input from the outside. Furthermore, the presence determination time is preferably set to 30 seconds or less. If the presence determination time is longer than 30 seconds, there is a risk that the presence will not be determined when, for example, the subject is temporarily positioned on the bed 36. It is more preferable that the presence determination time is set within a range of 0.5 seconds to 15 seconds, and is set to 1 second in this embodiment.

[0078] Furthermore, when the ballistocardiogram signal exceeds the body motion threshold γ and it is determined that the user A is present on the bed 36 for a predetermined time (e.g., 30 seconds) before and after the ballistocardiogram signal exceeds the body motion threshold γ, it is determined that the user A has made a body motion in the narrow sense, such as turning over in bed 36. Alternatively, a body motion determination time may be set, and when the state in which the ballistocardiogram signal exceeds the body motion threshold γ continues beyond the body motion determination time, it may be determined that the user A has made a body motion (turned over or sat up again) on the bed 36. In this embodiment, the body motion determination time is set to 0.5 seconds.

[0079] The body movement threshold γ is preferably set to a value greater than the presence threshold β, and in this embodiment, the body movement threshold γ is set to 30000 [digits].

[0080] 8 shows states (i) to (v) according to the magnitude relationship between the ballistocardiogram signal and the absence threshold α, the presence threshold β, and the body movement threshold γ, and the duration of the magnitude relationship. Each of states (i) to (v) will be described below.

[0081] 8(i), the ballistocardiogram signal is smaller than the absence threshold α immediately before, and it is determined that user A is not present (not present) on bed 36. After that, the ballistocardiogram signal exceeds the presence threshold β, but since this state does not continue beyond the presence determination time (1 second), it is determined in (i) that user A is not present on bed 36. Such a temporary peak can occur, for example, when user A touches the comforter on bed 36.

[0082] 8, in (ii), the previous state is determined to be non-existence, and the ballistocardiogram signal exceeds the presence threshold β, and this state continues beyond the presence determination time (1 second), so in (ii), it is determined that user A is present on bed 36. Note that in (ii), the ballistocardiogram signal exceeds the body movement threshold γ, and this state exceeds the body movement determination time, but in relation to the previous state, it is estimated that user A has started to lie down on bed 36, and body movement (turning over) is not determined.

[0083] In (iii) in Fig. 8, the state immediately before is determined to be on the bed 36, the ballistocardiogram signal exceeds the body motion threshold γ, and this state continues beyond the body motion determination time (0.5 seconds). In the state (iv) immediately after, the ballistocardiogram signal is approximately equal to or slightly smaller than the absence threshold α, but since the duration is shorter than the absence determination time (20 seconds), it is not determined to be absent. In other words, since it is determined that the user A is on the bed 36 for a predetermined time (e.g., 30 seconds) before and after the ballistocardiogram signal exceeds the body motion threshold γ, the state of (iii) is determined to be body motion (turning over or sitting up again).

[0084] 8, as described above, the ballistocardiogram signal is approximately equal to or slightly smaller than the absence threshold value α, but since the duration is shorter than the absence determination time (20 seconds), it is not determined that the user A is absent, and in consideration of the state immediately before, it is determined that the user A is present on the bed 36. Note that in (iv), it is believed that the ballistocardiogram signal has temporarily decreased due to a change in posture caused by turning over in bed, etc.

[0085] 8(v), the ballistocardiogram signal falls below the absence threshold α, and this state continues beyond the absence determination time (20 seconds), so it is determined that the patient is absent. In other words, when considering the state immediately before this, it is considered that the patient has left the bed 36.

[0086] In the above-described procedure, whether or not user A is present on bed 36 is determined from user A's ballistocardiogram, but whether or not user A is present on bed 36 may also be determined from user A's heart rate.

[0087] That is, a high-pass filter that passes frequency components of 4 Hz or higher (or a band-pass filter that passes frequency components of 4 Hz to 20 Hz) is used to extract components derived from ballistocardiogram from a detection signal based on the charge generated in piezoelectric layer 18, and the signal value is squared and amplified. Since components derived from ballistocardiogram include components derived from heartbeats, the amplified signal value is filtered with a band-pass filter that passes frequency components of 0.8 Hz to 2.0 Hz to extract the components derived from heartbeats. This results in a waveform of the heartbeat as shown in FIG. 9.

[0088] In this way, by using the heart rate signal value obtained based on the ballistocardiogram signal, a representative value within a predetermined time period may be calculated and compared with a pre-set absence threshold, presence threshold, body movement threshold, etc., to determine whether the user A is present on the bed 36. Note that the average value or maximum value for the immediately preceding 10 seconds may be adopted as this representative value. The absence threshold, presence threshold, and body movement threshold may be appropriately set according to the signal value to be compared (whether it is a ballistocardiogram signal or a heart rate signal, or whether the maximum value, minimum value, average value, median value, or sum is to be adopted as the representative value, etc.).

[0089] As described above, the absence determination unit 44 that determines whether user A is present on the bed 36 (performs an absence determination), the presence determination unit 46 that determines whether user A is present on the bed 36 (performs a presence determination), the body movement determination unit 48 that determines whether or not there is body movement of user A on the bed 36, such as turning over (performs a body movement determination), and the heartbeat waveform calculation unit 50 that calculates the heartbeat waveform from the amplified ballistocardiogram signal may be configured to include, for example, a computer of the analysis device 14 and a program installed on the computer.

[0090] As described above, the presence / absence determination device 10 of this embodiment does not determine the presence / absence based on body load (body pressure) as with conventional pressure sensors, but rather determines the presence / absence of user A based on heart rate and the ballistocardiogram based thereon, thereby reducing the risk of reduced detection accuracy or erroneous determination.

[0091] Furthermore, rather than immediately determining that the ballistocardiogram signal is absent when it falls below the absence threshold α, an absence determination time is set, and the ballistocardiogram signal is determined to be absent when the state in which the ballistocardiogram signal remains below the absence threshold α continues beyond the absence determination time. This makes it possible to avoid problems such as the ballistocardiogram signal being erroneously determined to be absent even if the ballistocardiogram signal temporarily decreases due to a change in posture, such as turning over in bed.

[0092] Furthermore, in this embodiment, a presence determination time is provided so that the presence is determined when the state in which the ballistocardiogram signal exceeds the presence threshold value β continues beyond the presence determination time, so that the risk of determining that the body is absent when it is present can be reduced. Furthermore, for body movements such as turning over in bed, the body movement is determined to have occurred when the ballistocardiogram signal exceeds the body movement threshold value and is determined to be present for a predetermined time before and after that, so that a more accurate determination can be made compared to when the body movement is determined to have occurred simply because the body movement exceeds the body movement threshold value.

[0093] In addition, in this embodiment, the ballistocardiogram signal or heart rate signal compared with the absence threshold α, the presence threshold β, and the body motion threshold γ is set as a representative value within a predetermined time, and the representative value may be, for example, a maximum value, a minimum value, an average value, a median value, or a sum. By adopting the maximum value as the representative value, the numerical value of the ballistocardiogram signal can be increased overall, and a highly accurate judgment can be made. Furthermore, by adopting the minimum value as the representative value, the numerical value of the external vibration input as noise can be suppressed to a small value, and the risk of erroneous judgment can be reduced. Furthermore, by adopting the average value as the representative value, both the effect of adopting the maximum value and the effect of adopting the minimum value as described above can be achieved, and a well-balanced presence / absence judgment device can be provided.

[0094] Furthermore, in this embodiment, the absence threshold value α and the presence threshold value β are set independently as different values. That is, for example, the presence threshold value β can be set relatively large, and this can avoid a problem in which an absence is judged to be present due to external vibration input as noise. Similarly, the absence threshold value α can be set relatively small, and this can avoid a problem in which an absence is judged to be absent even in a presence state. That is, it is preferable that the absence threshold value α and the presence threshold value β are largely separated from each other, and for example, they can be set to 3 times or more, 5 times or more, or even 20 times or more depending on the usage mode.

[0095] Furthermore, accuracy can be improved by amplifying the ballistocardiogram signal using the signal amplifier 42, and the amplified ballistocardiogram signal can be used to calculate a heart rate waveform, which can then be used to determine whether or not user A is present on the bed 36.

[0096] 10 shows a presence / absence determining device 60 according to a second embodiment of the present invention. In the following description, the same members and parts as those in the first embodiment are denoted by the same reference numerals in the drawing and the description thereof will be omitted.

[0097] The presence / absence determination device 60 is composed of a piezoelectric sensor sheet 12 that outputs a detection signal in response to the body movement (vibration) of user A, and an analysis device 62 that analyzes the detection signal output from the piezoelectric sensor sheet 12.

[0098] The analysis device 62 is electrically connected to the piezoelectric sensor sheet 12 by wiring via the controller 26. The analysis device 62 is capable of calculating signals controlled by the controller 26. The analysis device 62 includes an absence determination unit 44 and a presence determination unit 46.

[0099] The analysis device 62 includes a vital frequency analysis section 64 that performs frequency analysis on the detection signal of the piezoelectric sensor sheet 12 to calculate a vital spectrum, which is a power spectrum related to the ballistocardiogram and respiration of the user A.

[0100] The vital frequency analysis unit 64 performs frequency analysis on the detection signal from the piezoelectric sensor sheet 12 to calculate a vital spectrum that is a power spectrum that combines a ballistocardiogram spectrum, which is a power spectrum caused by ballistocardiogram, and a respiratory spectrum, which is a power spectrum caused by respiration. In the vital spectrum, the respiratory spectrum is not essential, and in cases where breathing temporarily stops during sleep due to sleep apnea syndrome, for example, the vital spectrum does not include the respiratory spectrum. The vital frequency analysis unit 64 executes frequency analysis processing using a fast Fourier transform (FFT), and is configured by, for example, a computer on which a frequency analysis program or the like is installed.

[0101] The ballistocardiogram spectrum mainly appears in a frequency range of about 1 Hz to 5 Hz, and the respiratory spectrum mainly appears in a frequency range of about 0.1 Hz to 2 Hz. In the frequency analysis, the frequency range to be processed as the vital spectrum is appropriately set, and for example, the vital spectrum is calculated as a power spectrum in the frequency range of 0.1 Hz to 5 Hz.

[0102] The analysis device 62 includes a representative value setting unit 66 that calculates a representative value of the vital spectrum calculated by the vital frequency analysis unit 64. The representative value of the vital spectrum is not particularly limited and is selected according to the purpose, and may be, for example, the maximum value, minimum value, average value, median value, or sum of the vital spectrum at a predetermined time. The representative value setting unit 66 of this embodiment executes a process of determining the maximum value of the vital spectrum as the representative value of the vital spectrum. The representative value setting unit 66 is configured by, for example, a computer in which a calculation processing program for the representative value, etc. is installed.

[0103] The analysis device 62 includes a ballistocardiogram signal acquisition unit 68 that acquires a ballistocardiogram signal based on the representative value of the vital spectrum set by the representative value setting unit 66. The ballistocardiogram signal acquisition unit 68 is configured by, for example, a computer in which a ballistocardiogram signal generation processing program or the like is installed.

[0104] The analysis device 62 includes a noise frequency analysis unit 70 that calculates a noise spectrum, which is a power spectrum in a frequency range higher than the frequency range of the vital spectrum (vital frequency range), by frequency analyzing the detection signal of the piezoelectric sensor sheet 12. The noise frequency analysis unit 70 executes frequency analysis processing using a fast Fourier transform (FFT), and is configured by, for example, a computer in which a frequency analysis program or the like is installed. Note that the noise spectrum is preferably a power spectrum in a frequency range that is less affected by ballistocardiogram and respiration, and is calculated as a power spectrum of, for example, 20 Hz to 25 Hz.

[0105] The representative value setting unit 66 calculates a representative value of the noise spectrum calculated by the noise frequency analysis unit 70. The representative value of the noise spectrum is not particularly limited and is selected according to the purpose, but for example, the maximum value, minimum value, average value, median value, sum, etc. of the noise spectrum in a predetermined time are adopted. The representative value setting unit 66 of this embodiment executes a process of determining the average value of the noise spectrum as the representative value of the noise spectrum.

[0106] The analysis device 62 includes a noise signal acquisition unit 72 that acquires a noise signal based on the representative value of the noise spectrum set by the representative value setting unit 66. The noise signal acquisition unit 72 is configured by, for example, a computer in which a noise signal generation processing program or the like is installed.

[0107] The analysis device 62 includes an S / N ratio calculation unit 74 that calculates the ratio (S / N ratio) of the ballistocardiogram signal as a signal to the noise signal as a noise. The S / N ratio calculation unit 74 is configured by, for example, a computer in which a calculation processing program or the like is installed.

[0108] Then, the absence determination unit 44 and the presence determination unit 46 perform the presence / absence determination based on the ratio of the ballistocardiogram signal to the noise signal calculated by the S / N ratio calculation unit 74. The absence determination unit 44 compares the calculated S / N ratio with a preset absence threshold, and performs the absence determination when the S / N ratio is continuously below the absence threshold for a predetermined absence determination time or more. The presence determination unit 46 compares the calculated S / N ratio with a preset presence threshold, and performs the presence determination when the S / N ratio is continuously above the presence threshold for a predetermined presence determination time or more. Note that the absence threshold, the presence threshold, the absence determination time, and the presence determination time are all appropriately set according to the magnitude of the input to the piezoelectric sensor sheet 12 (signal strength), noise from the surrounding environment, the required determination accuracy, and the like, and are not particularly limited.

[0109] Such a presence / absence determination device 60 is used, for example, to monitor the user A while he / she sleeps, and determines whether the user A is on the bed 36 or not. The bed 36 as a detection area on which the user A lies is provided with a mattress 78 as a cushion body placed on a floor board 76, and the sensor body 16 of the presence / absence determination device 60 is disposed between the floor board 76 and the mattress 78. In short, the sensor body 16 is disposed under the mattress 78, and vibrations (ballistocardiogram, body movement, etc.) that the user A exerts on the mattress 78 are indirectly input to the sensor body 16 via the mattress 78. The mattress 78 may be covered with a sheet for the purpose of preventing dirt adhesion and wear, and for example, the sensor body 16 and the mattress 78 may be covered with a sheet. Note that the sensor body 16 is desirably disposed near the chest of the user A in a top view, as in the first embodiment. The sensor body 16 may be positioned with respect to the floor board 76 or the mattress 78 by a band, a hook, or the like. In particular, when applied to a nursing bed having a back-raising function, it is desirable to position the sensor body 16 to prevent it from shifting or falling off due to the back-raising function. In addition, when the sensor body 16 is positioned relative to the bed 36, it is desirable to make the positioning releasable, and preferably the sensor body 16 is detachable from the bed 36.

[0110] With the presence / absence determining device 60 set on the bed 36 in this manner, input changes resulting from the heartbeat, breathing, body movements, etc. of the user A are detected by the piezoelectric sensor sheet 12. Fig. 11 shows an example of the detection results by the piezoelectric sensor sheet 12 as a graph. In the graph of Fig. 11, the vertical axis represents the detected amplitude, in other words, the strength of the detected signal, in digits, and the horizontal axis represents time, in seconds. Note that the graph of Fig. 11 shows the raw waveform of the detection signal output from the piezoelectric sensor sheet 12, and includes not only vibration waveforms resulting from the ballistocardiogram, breathing, body movements, etc. of the user A, but also electromagnetic noise waveforms and vibration waveforms input from the floor to the bed 36.

[0111] Then, the analysis device 62 determines whether or not the user A is in bed 36 by executing the presence / absence determination shown in the flowchart of Fig. 12 based on the detection signal transmitted from the piezoelectric sensor sheet 12. Below, examples of presence / absence determination by the presence / absence determining device 60 for each of the three characteristic time periods T1, T2, and T3 in Fig. 11 will be described.

[0112] 11 is a time period during which the user A is out of bed 36. As shown in an enlarged view in FIG 13, during T1, the waveform of the detection signal output by the piezoelectric sensor sheet 12 is approximately flat.

[0113] In step (hereinafter, S) 0 of FIG. 12, the detection signal sent to the analysis device 62 is subjected to frequency analysis processing by fast Fourier transform (FFT) by the vital frequency analysis unit 64 and the noise frequency analysis unit 70 in S1. The result of frequency analysis of the detection signal at T1 is shown in the graph in FIG. 14. In the graph in FIG. 14, the horizontal axis is frequency and the vertical axis is the intensity of the power spectrum. According to the graph in FIG. 14, an increase in the power spectrum due to noise is confirmed at frequencies lower than 0.1 Hz, but the vital spectrum, which is the power spectrum in the frequency range of 0.1 Hz to 5 Hz, has an extremely small numerical value. In addition, the noise spectrum, which is the power spectrum in the frequency range of 20 Hz to 25 Hz, also has an extremely small numerical value.

[0114] In S2, the ballistocardiogram signal acquisition unit 68 acquires a ballistocardiogram signal based on the representative value of the power spectrum (vital spectrum) of 0.1 Hz to 5 Hz set by the representative value setting unit 66. The representative value of the vital spectrum is not particularly limited, but for example, the maximum value, minimum value, average value, median value, and sum of the vital spectrum are preferably used. In this embodiment, the maximum value is used as the representative value of the vital spectrum.

[0115] In S3, the noise signal acquisition unit 72 acquires a noise signal based on the representative value of the power spectrum (noise spectrum) of 20 Hz to 25 Hz set by the representative value setting unit 66. The representative value of the noise signal is not particularly limited, but for example, the maximum value, minimum value, average value, median value, and sum of the noise spectrum are preferably adopted. In this embodiment, the average value is adopted as the representative value of the noise spectrum. The calculation method of the representative value of the vital spectrum and the calculation method of the representative value of the noise spectrum may be the same, for example, by taking the average value of both, or may be different from each other as in this embodiment.

[0116] In S4, the S / N ratio calculation unit 74 of the analysis device 62 calculates the ratio of the ballistocardiogram signal based on the representative value of the vital spectrum to the noise signal based on the representative value of the noise spectrum as the signal / noise ratio (S / N ratio).

[0117] In S5, it is determined whether the user A was present on the bed 36 at the time of the previous determination. Note that, in the first S5 determination, it is determined that the user A was present (y). That is, in a case where the presence determination device 60 is used to watch over a patient (user A), the presence of the user A immediately after going to sleep is confirmed by a caregiver or the like, so the first determination is that the user is in bed. Thereafter, by monitoring the user A getting out of bed using the presence determination device 60, the first getting out of bed can be accurately grasped by the absence determination, which has a longer determination time than the presence determination and is less likely to cause erroneous determination due to the influence of noise, etc. Note that, as described above, if the first S5 determination is the presence (y), the determination result of S6 is always a presence determination for 20 seconds from the start of the determination, but since the time is as short as 20 seconds, it is unlikely to be a burden for the caregiver or the like to visually check the user A only during that time, and there is almost no risk of erroneous determination during that time becoming a serious problem.

[0118] However, in the initial S5 judgment, it may be judged as not present (n). In this way, in the unlikely event of an erroneous judgment, it will be an erroneous judgment on the safe side of judging that user A is not present even though he is actually present on the bed 36, and problems are unlikely to occur. In addition, the presence judgment time (2 seconds) set in S7 is shorter than the absence judgment time (20 seconds) set in S6, and normal judgment can be made more quickly, further shortening the time that busy caregivers are confined.

[0119] When it is determined in S5 that the user A is present on the bed 36 (y), the absence determination unit 44 determines whether the user A has left the bed 36 in S6. That is, if the state in which the S / N ratio stored in S4 is smaller than the absence threshold (below the absence threshold) continues for a period exceeding ...

[0120] When it is determined in S5 that the user A is not present on the bed 36 (n), the presence determination unit 46 determines the presence of the user A in S7. That is, when the state in which the S / N ratio stored in S4 is greater than the presence threshold (exceeds the presence threshold) continues beyond the presence determination time set in advance, the presence determination is made and it is determined that the user A is present on the bed 36 (in bed). On the other hand, when the state in which the S / N ratio is greater than the presence threshold does not occur or does not continue beyond the presence determination time, it is determined that the user A is not on the bed 36 (continues to get out of bed). The magnitude of the presence threshold is appropriately set according to the performance of the piezoelectric sensor sheet 12 and the magnitude of noise in the surrounding environment. The length of the presence determination time is appropriately set according to the required difficulty of erroneous determination, and is preferably set to, for example, 2 seconds. Preferably, the presence determination time is shorter than the non-presence determination time.

[0121] According to the power spectrum of T1 shown in Fig. 14, the S / N ratio is small, so that in S7, it is determined that the user A continues to get out of bed without making a presence determination. Therefore, in T1, it is determined that the user A is not present on the bed 36.

[0122] Time period T2 shown in Fig. 11 is a time period when user A is in bed 36 and breathing of user A temporarily stops. As shown in an enlarged view in Fig. 15, at T2, the waveform of the detection signal output by the piezoelectric sensor sheet 12 does not have a large amplitude waveform due to breathing, and a small amplitude waveform due to ballistocardiography derived from the heartbeat appears periodically. Note that, for the presence / absence determination of T2, similar to the presence / absence determination of T1, the process of calculating the representative value and S / N ratio, etc. is executed, but for the sake of simplicity, the process substantially the same as that of T1 will not be described.

[0123] FIG. 16 is a graph showing the results of frequency analysis of the detection signal at T2. At T2, the vital spectrum is the ballistocardiogram spectrum not including the respiratory spectrum. According to FIG. 16, the vital spectrum appears up to about 20 Hz, and the vital spectrum has a large numerical value especially in the frequency range of about 0.1 Hz to 3 Hz. On the other hand, the noise spectrum, which is the power spectrum in the frequency range of 20 Hz to 25 Hz, has an extremely small numerical value, similar to T1. Therefore, at T2, the S / N ratio, which is the ratio of the ballistocardiogram signal to the noise signal, is large compared to T1.

[0124] In the flowchart of the determination process shown in Fig. 12, in the presence / absence determination of T2, it is determined in S5 that the user A was in bed in the previous determination. Therefore, in S6, it is determined whether the state in which the S / N ratio is less than the absence determination threshold continues for 20 seconds or more. Since the S / N ratio increases due to ballistocardial movement in T2, the absence determination is denied in the determination of S6, and it is determined that the user A is in bed 36.

[0125] In this way, even if the user's breathing temporarily stops and there is no respiratory spectrum, the presence or absence can be accurately determined by the ballistocardiogram signal that does not include a respiratory spectrum based on the ballistocardiogram spectrum.

[0126] Time period T3 shown in Fig. 11 is a time period when user A is present in bed 36 and breathing. As shown in an enlarged view in Fig. 17, at T3, the waveform of the detection signal output by the piezoelectric sensor sheet 12 is a composite waveform of a large amplitude waveform due to breathing and a small amplitude waveform due to ballistocardiography derived from the heartbeat. Note that, for the presence / absence determination at T3, a description of the same process as that at T1 will be omitted.

[0127] FIG. 18 is a graph showing the result of frequency analysis of the detection signal at T3. According to FIG. 18, the vital spectrum, which is a combination of the ballistocardiogram spectrum caused by the ballistocardiogram and the respiratory spectrum caused by the respiratory movement, appears up to about 20 Hz, and the numerical value of the vital spectrum is particularly large in the frequency range of about 0.1 Hz to a dozen Hz. On the other hand, the numerical value of the noise spectrum, which is the power spectrum in the frequency range of 20 Hz to 25 Hz, is extremely small. Therefore, compared to T1, T3 has a high S / N ratio, which is the ratio of the representative value (maximum value) of the ballistocardiogram signal based on the vital spectrum to the representative value (average value) of the noise signal based on the noise spectrum. Furthermore, in T3, the vital spectrum constituting the ballistocardiogram signal has a respiratory spectrum in addition to the ballistocardiogram spectrum, so that the ballistocardiogram signal becomes large and the S / N ratio becomes larger compared to T2, whose vital spectrum does not include the respiratory spectrum.

[0128] In the flowchart of the determination process shown in Fig. 12, in the presence / absence determination at T3, it is determined in S5 that the user A was in bed in the previous determination. Therefore, in S6, it is determined whether the state in which the S / N ratio is less than the absence determination threshold has continued for 20 seconds or more. Since the S / N ratio increases due to ballistocardial movement and breathing at T3, the absence determination is denied in the determination at S6, and it is determined that the user A is in bed 36.

[0129] In this way, when the user A is lying on the bed 36 breathing normally, a larger S / N ratio can be obtained from the ballistocardiogram signal generated based on the vital spectrum including the respiratory spectrum in addition to the ballistocardiogram spectrum, compared to when breathing has stopped. Therefore, a highly accurate presence / absence determination can be performed with less chance of erroneous determination.

[0130] According to the presence / absence determining device 60 of this embodiment, even when the sensor body 16 of the piezoelectric sensor sheet 12 is placed under the mattress 78 and the input to the sensor body 16 is buffered and reduced by the mattress 78, it is possible to realize highly accurate determination based on the ballistocardiogram signal by frequency analysis. Note that in the presence / absence determining device 60 of this embodiment, the sensor body 16 of the piezoelectric sensor sheet 12 can also be placed above the mattress 78.

[0131] By placing the sensor main body 16 under the mattress 78, it is possible to prevent the sensor main body 16 from bending in the thickness direction or shifting in position relative to the mattress 78 due to bodily movements of the user A, such as getting in and out of bed and turning over. Moreover, the influence of the external environment, such as wind, on the sensor main body 16 is reduced by being covered by the mattress 78, and the detection signal can be obtained with high accuracy.

[0132] The non-existence determination unit 44 and the presence determination unit 46 perform the non-existence determination or the presence determination by comparing the S / N ratio, which is the ratio of the ballistocardiogram signal to the noise signal, with the threshold value. Therefore, for example, when a noise (white noise) that is approximately uniform in the entire frequency range is input, the influence of the noise is reduced, and an accurate determination can be performed. However, the non-existence determination unit 44 and the presence determination unit 46 may perform the non-existence determination or the presence determination by comparing the ballistocardiogram signal with the threshold value, and in that case, the noise frequency analysis unit 70, the noise signal acquisition unit 72, and the S / N ratio calculation unit 74 can be omitted.

[0133] The ballistocardiogram signal acquiring unit 68 acquires the ballistocardiogram signal based on the representative value of the vital spectrum, and the noise signal acquiring unit 72 acquires the noise signal based on the representative value of the noise spectrum. This allows for highly accurate determination of the presence or absence, reduction in erroneous determination due to noise, and simplification of the calculation process for determining the presence or absence.

[0134] In particular, in this embodiment, the representative value of the vital spectrum is set to the maximum value, and the representative value of the noise spectrum is set to the average value, thereby making it possible to obtain a high S / N ratio and, in the case where a large noise such as electromagnetic noise occurs instantaneously, the influence of the noise can be suppressed.

[0135] As in the first embodiment, a body movement determination unit may be provided in the analysis device 62 to determine body movements such as turning over of the user A. In this case, the body movement determination unit determines body movements based on, for example, a result of comparing the S / N ratio calculated by the S / N ratio calculation unit 74 with a body movement threshold value.

[0136] Although the embodiments of the present invention have been described above, the present invention should not be interpreted as being limited to the specific descriptions in the embodiments, and can be implemented in various forms with various changes, modifications, improvements, etc. based on the knowledge of those skilled in the art.

[0137] Representative values ​​are characteristic values ​​that summarize the distribution trend, and include quantitative representative values ​​such as the arithmetic mean, geometric mean, harmonic mean, and square mean, and positional representative values ​​such as the median, mode, quartile, maximum, and minimum. In general, quantitative representative values ​​can grasp the summarized characteristics by including all values, while positional representative values ​​can show the characteristics with reduced influence of extreme values ​​in the data. Therefore, for example, when a specific noise is concerned, it may be better to adopt the mode rather than the maximum value, or to adopt the minimum value (maximum noise). In the case of noise that is difficult to identify (such as turning over in bed, which has minimum and maximum values), the average value may be adopted, or the maximum value, average value, sum, etc. may be adopted in consideration of simplifying the calculation.

[0138] The specific numerical values ​​for the filtering frequency, threshold value, judgment time, etc. described in the above embodiment are merely examples and should not be interpreted in a restrictive manner. They can be appropriately adjusted depending on, for example, the user's condition, environment, etc.

[0139] Furthermore, the amplification of the ballistocardiogram signal by the signal amplifier is not limited to the square, but is preferably an even power in terms of positive and negative. Also, since a smaller number is easier to calculate, it is preferable to use the square. However, the signal amplifier is not essential, and it may be determined whether or not user A is present in the detection area based on the ballistocardiogram signal value shown in the waveform of FIG. 6 described above.

[0140] Furthermore, the detection area is not limited to a bed, but may be, for example, a chair. In other words, by applying the presence / absence determination device according to the present invention to chairs or seats in restaurants, movie theaters, and trains, it is possible to easily check the vacancy status, etc. Furthermore, the present invention originally includes each of the inventions described in (i) to (xix) below, and the configurations and effects thereof will be described below. The present invention relates to (i) A presence / absence determination device for determining whether or not a living organism is present on a detection area, the presence / absence determination device comprising: a flexible piezoelectric sensor sheet that is laid in the detection area and outputs a detection signal corresponding to an input vibration; a ballistocardiogram signal acquisition unit that extracts a ballistocardiogram signal corresponding to the ballistocardiogram from the detection signal of the piezoelectric sensor sheet; and an absence determination unit that performs an absence determination that the living organism is not present on the detection area based on the ballistocardiogram signal, the absence determination unit performing the absence determination when the state in which the ballistocardiogram signal is below an absence threshold continues beyond an absence determination time. (ii) the presence / absence determining device according to (i), wherein the absence determining time is set within a range of 0.5 seconds to 60 seconds; (iii) the presence / absence determination device according to (i) or (ii), in which the absence determination unit performs the absence determination by comparing a representative value of the ballistocardiogram signal within a predetermined time period with the absence threshold value; (iv) the presence / absence determination device according to (i) or (ii), in which the non-existence determination unit performs the non-existence determination by comparing any one of a maximum value, a minimum value, an average value, a median value, and a sum of the ballistocardiogram signal within a predetermined time with the non-existence threshold value; (v) a presence / absence determination device according to any one of (i) to (iv), which has a presence determination unit that performs a presence determination of the living body on the detection area based on the ballistocardiogram signal, and the presence determination unit performs the presence determination when a state in which the ballistocardiogram signal exceeds a presence threshold continues beyond a presence determination time; (vi) The presence / absence determining device according to (v), wherein the presence determination time is set within a range of 0.5 seconds to 30 seconds. (vii) The presence / absence determination device according to (v) or (vi), wherein the presence determination unit performs the presence determination by comparing a representative value of the ballistocardiogram signal within a predetermined time period with the presence threshold value. (viii) The presence / absence determination device according to (v) or (vi), in which the presence determination unit performs the presence determination by comparing any one of a maximum value, a minimum value, an average value, a median value, and a sum of the ballistocardiogram signal within a predetermined time with a presence threshold value; (ix) The presence / absence determination device according to any one of (v) to (viii), wherein the presence threshold and the absence threshold are set independently as different values ​​from each other. (x) the presence / absence determination device according to (ix), wherein the presence threshold is set to be three times or more the absence threshold; (xi) a body movement determination unit that determines body movement of the living body on the detection area based on the ballistocardiogram signal, and a body movement threshold value used for the body movement determination in the body movement determination unit is set to a value greater than the presence threshold value; The presence / absence determination device according to any one of (v) to (x), wherein the body movement determination unit detects the body movement of the living body and performs the body movement determination when the value of the ballistocardiogram signal exceeds the body movement threshold and the presence determination unit detects the presence of the living body for a predetermined time before and after the value of the ballistocardiogram signal exceeds the body movement threshold and performs the presence determination; (xii) The presence / absence determination device according to any one of (i) to (xi), comprising a signal amplifier that amplifies the ballistocardiogram signal; (xiii) the presence / absence determination device according to (xii), further comprising a cardiac waveform calculation unit for calculating a cardiac waveform from the ballistocardiogram signal amplified by the signal amplification unit; (xiv) The presence / absence determination device according to any one of (i) to (xiii), further comprising a vital frequency analysis unit that performs frequency analysis on the detection signal of the piezoelectric sensor sheet to calculate a vital spectrum including a power spectrum caused by the ballistocardiogram of the living body, and the ballistocardiogram signal acquisition unit acquires the ballistocardiogram signal based on the vital spectrum; (xv) the presence / absence determination device according to (xiv), wherein the vital spectrum is a power spectrum having both a ballistocardiogram spectrum, which is a power spectrum caused by the ballistocardiogram of the living body, and a respiration spectrum, which is a power spectrum caused by the respiration of the living body; (xvi) The presence / absence determination device according to (xiv) or (xv), wherein the ballistocardiogram signal is acquired based on a representative value of the vital spectrum. (xvii) The presence / absence determining device according to (xvi), wherein the representative value of the vital spectrum is any one of a maximum value, a minimum value, an average value, a median value, and a sum of the vital spectrum. (xviii) The presence / absence determining device according to any one of (xiv) to (xvii), further comprising a noise frequency analysis unit that performs frequency analysis on the detection signal of the piezoelectric sensor sheet to calculate a noise spectrum, which is a power spectrum in a frequency range higher than a vital frequency range, which is a frequency range of the vital spectrum, and the absence determination by the absence determining unit is performed by comparing an S / N ratio, which is a ratio of the ballistocardiogram signal to a noise signal based on the noise spectrum, with the absence threshold value. (xix) The presence / absence determining device according to any one of (xiv) to (xviii), wherein the piezoelectric sensor sheet is disposed under a cushion body on which the living body is placed. This includes inventions relating to. In the invention described in (i) above, by judging absence based on ballistocardiogram, it is possible to make a more accurate judgment compared to a judgment based on pressure due to the body weight, etc. Also, in regard to the judgment of absence when a patient leaves the bed, which can be a problem when watching over a patient, the absence is not immediately judged to be absent when the amplitude of the vibration input to the piezoelectric sensor sheet becomes small simply due to a change in posture caused by turning over in bed, but a more accurate judgment is possible by setting an absence judgment time. In the invention described in (ii) above, accurate determination is possible by setting the non-existence determination time within the above range. That is, if the non-existence determination time is too short, there is a risk of erroneous determination occurring when the level of the ballistocardiogram signal temporarily drops due to erroneous detection, etc. Also, if the non-existence determination time is too long, there is a risk of non-existence not being determined even if the subject leaves the detection area once and then returns. In the invention described in (iii) above, by adopting a representative value according to the purpose, it is possible to achieve highly accurate determination of the presence / absence, reduce erroneous determinations due to noise, and simplify the calculation process for determining the presence / absence. In the invention described in (iv) above, for example, by adopting the maximum value of the ballistocardiogram signal within a predetermined time as the value to be compared with the non-existence threshold, the maximum amplitude of the heartbeat waveform can be obtained easily, and the presence or absence can be determined with high accuracy. Also, by adopting the minimum value, average value, or median value of the ballistocardiogram signal within a predetermined time, it becomes difficult to erroneously determine the presence of the object when the object is not present due to noise. Alternatively, by adopting the sum of the ballistocardiogram signal, the calculation process for determining the absence of the object becomes simple, thereby reducing the load. In the invention described in (v) above, even if the vibration level temporarily increases due to external vibration noise or the like, a more accurate judgment is possible without immediately misjudging that the object is present. In the invention described in (vi) above, accurate judgment is possible by setting the presence judgment time within the above range. That is, if the presence judgment time is too short, there is a risk that an erroneous presence judgment will be made due to external vibrations, etc. Also, if the presence judgment time is too long, there is a risk that the presence judgment will not be made correctly when the object is in the detection area for only a short time. In the invention described in (vii) above, by adopting a representative value according to the purpose, it is possible to achieve highly accurate determination of the presence / absence, reduce erroneous determinations due to noise, and simplify the calculation process for determining the presence / absence. In the invention described in (viii) above, for example, by adopting the maximum value of the ballistocardiogram signal within a predetermined time as the value to be compared with the presence threshold, the maximum amplitude of the ballistocardiogram waveform can be obtained easily, and the presence or absence can be determined with high accuracy. Also, by adopting the minimum value, average value, or median value of the ballistocardiogram signal within a predetermined time, it becomes difficult to erroneously determine the presence of a substance when it is not present due to noise. Alternatively, by adopting the sum of the ballistocardiogram signal, the calculation process for determining the presence of a substance becomes simple, thereby reducing the load. In the invention described in (ix) above, presence or absence can be determined with greater accuracy. In the invention described in (x) above, presence or absence can be determined with even greater accuracy. In the invention described in (xi) above, body movements such as turning over in a lying position or shifting in a sitting position can be detected more accurately. In the invention described in (xii) above, the presence and absence determination is performed based on the ballistocardiogram signal amplified by the signal amplifier, thereby improving the determination accuracy. In the invention described in (xiii) above, when performing non-presence determination based on a ballistocardiogram signal, it is possible to suppress the influence of noise, etc., and improve the determination accuracy by performing the determination using a heartbeat waveform obtained from the ballistocardiogram signal, rather than directly using the ballistocardiogram signal. In addition, for example, the heartbeat waveform can be displayed on a monitor, and the presence or absence of the user can be determined based on the presence or absence of the heartbeat waveform displayed on the monitor. In the invention described in (xiv) above, even when the amplitude of the vibration input to the piezoelectric sensor sheet is small and the detection signal is weak, it is possible to determine the presence or absence with high accuracy based on the frequency analysis result of the detection signal. Therefore, even when the amplitude of the input to the piezoelectric sensor sheet is small, for example, because the piezoelectric sensor sheet is laid under a mattress, it is possible to accurately determine the presence or absence of a user. In the invention described in (xv) above, the vital spectrum includes a respiratory spectrum that is larger than the ballistocardiogram spectrum, so that the vital spectrum can be obtained larger. Therefore, even if the detection signal is weak, the ballistocardiogram signal obtained based on the vital spectrum can be obtained stronger, and the presence / absence determination can be performed with high accuracy. In the invention described in (xvi) above, by adopting a representative value according to the purpose, it is possible to achieve highly accurate determination of the presence / absence, reduce erroneous determinations due to noise, and simplify the calculation process for determining the presence / absence. In the invention described in (xvii) above, for example, by adopting a ballistocardiogram signal based on the maximum value of the vital spectrum as a value to be compared with the non-existence threshold, the presence or absence can be determined with high accuracy. Also, by adopting a ballistocardiogram signal based on the minimum value, average value, or median value of the vital spectrum, it becomes difficult to erroneously determine that the presence is erroneously determined due to noise when the presence is absent. Alternatively, by adopting a ballistocardiogram signal based on the sum of the vital spectrum, the calculation process for determining the absence is simplified, thereby reducing the load. In the invention described in (xviii) above, the S / N ratio, which is the ratio of the ballistocardiogram signal to the noise signal, is compared with the non-existence threshold to determine the presence or absence, so that, for example, the power spectrum of the vital frequency range is raised by white noise, and erroneous determination that the signal is present when the signal is not present is unlikely to occur. Preferably, the noise signal is acquired based on a representative value of the noise spectrum. The representative value of the noise spectrum is appropriately selected from, for example, the maximum value, minimum value, average value, median value, sum, etc. of the noise spectrum. By adopting a representative value according to the purpose, it is possible to achieve highly accurate determination of the presence or absence, reduction of erroneous determination due to noise, and simplification of the calculation process for determining the presence or absence. In the invention described in (xix) above, the cushion body on the piezoelectric sensor sheet prevents the piezoelectric sensor sheet from shifting or deforming due to the user's body movements. In addition, because the upper surface of the piezoelectric sensor sheet is covered with the cushion body, even if a highly sensitive piezoelectric sensor sheet is used, the detection signal is less susceptible to the effects of wind, etc. [Explanation of symbols]

[0141] 10 Presence / absence determination device (first embodiment) 12 Piezoelectric sensor sheet 14 Analyzer 16 Sensor body 18 Piezoelectric layer 20a,20b electrode layer 22a,22b Protective layer 24 Pressure sensing part 26 Controller 28 Connectors 30a, 30b Wiring 32 Monitor section 36 Beds 38 Belt section 40 Ballistocardiogram signal acquisition unit 42 Signal amplifier 44 Absence determination part 46 Presence determination part 48 Body movement determination unit 50 Heart rate waveform calculation unit A User (living body) α Absence threshold β Existence threshold γ Body movement threshold 60 Presence / absence determination device (second embodiment) 62 Analyzer 64 Vital Frequency Analysis Unit 66 Representative value setting section 68 Ballistocardiogram signal acquisition unit 70 Noise Frequency Analysis Section 72 Noise signal acquisition unit 74 S / N ratio calculation section 76 Floorboards 78 Mattress

Claims

1. A presence / absence determination device for determining whether or not a living organism is present in a detection area, comprising: a flexible piezoelectric sensor sheet that is laid in the detection area and outputs a detection signal in response to an input vibration; a ballistocardiogram signal acquisition unit that extracts a ballistocardiogram signal corresponding to the ballistocardiogram from the detection signal of the piezoelectric sensor sheet; and a non-existence determination unit that performs a non-existence determination of the living body not being present on the detection area based on the ballistocardiogram signal, When the state where the ballistocardiogram signal is below the non-existence threshold continues beyond the non-existence determination time, the non-existence determination unit performs the non-existence determination, a presence determination unit that determines whether the living body is present on the detection area based on the ballistocardiogram signal; The presence determination unit performs the presence determination when a state in which the ballistocardiogram signal exceeds a presence threshold continues beyond a presence determination time, and a body movement determination unit that performs body movement determination to determine body movement of the living body on the detection area based on the ballistocardiogram signal, and a body movement threshold value used for the body movement determination in the body movement determination unit is set to a value greater than the presence threshold value; A presence / absence determination device in which the body movement determination unit detects the body movement of the living body and performs the body movement determination when the value of the ballistocardiogram signal exceeds the body movement threshold and the presence determination unit detects the presence of the living body for a predetermined period of time before and after the value of the ballistocardiogram signal exceeds the body movement threshold and performs the presence determination.

2. 2. The presence / absence determining device according to claim 1, wherein the presence determination time is set within a range of 0.5 to 30 seconds.

3. The presence / absence determining device according to claim 1 or 2, wherein the presence determining unit performs the presence determination by comparing a representative value of the ballistocardiogram signal within a predetermined time period with the presence threshold value.

4. 3. The presence / absence determining device according to claim 1 or 2, wherein the presence determining unit performs the presence determination by comparing any one of the maximum value, minimum value, average value, median value, and sum of the ballistocardiogram signal within a predetermined time period with a presence threshold value.

5. 5. The presence / absence determining device according to claim 1, wherein the presence threshold and the absence threshold are set independently as different values ​​from each other.

6. The presence / absence determining device according to claim 5 , wherein the presence threshold is set to be three times or more larger than the absence threshold.

7. a vital frequency analysis unit that performs frequency analysis on the detection signal of the piezoelectric sensor sheet to calculate a vital spectrum including a power spectrum caused by ballistocardial movement of the living body; The presence / absence determination device according to any one of claims 1 to 6, wherein the ballistocardiogram signal acquisition unit acquires the ballistocardiogram signal based on the vital spectrum.

8. A presence / absence determination device for determining whether or not a living organism is present in a detection area, comprising: a flexible piezoelectric sensor sheet that is laid in the detection area and outputs a detection signal in response to an input vibration; a ballistocardiogram signal acquisition unit that extracts a ballistocardiogram signal corresponding to the ballistocardiogram from the detection signal of the piezoelectric sensor sheet; and a non-existence determination unit that performs a non-existence determination of the living body not being present on the detection area based on the ballistocardiogram signal, When the state where the ballistocardiogram signal is below the non-existence threshold continues beyond the non-existence determination time, the non-existence determination unit performs the non-existence determination, a vital frequency analysis unit that performs frequency analysis on the detection signal of the piezoelectric sensor sheet to calculate a vital spectrum including a power spectrum caused by ballistocardial movement of the living body; The ballistocardiogram signal acquisition unit acquires the ballistocardiogram signal based on the vital spectrum, a noise frequency analysis unit that performs frequency analysis on the detection signal of the piezoelectric sensor sheet to calculate a noise spectrum, which is a power spectrum in a frequency range higher than a vital frequency range, which is a frequency range of the vital spectrum; A presence / absence determination device in which the absence determination is performed by the absence determination unit by comparing an S / N ratio, which is the ratio of the ballistocardiogram signal to a noise signal based on the noise spectrum, with the absence threshold value.

9. The presence / absence determination device as described in claim 7 or 8, wherein the vital spectrum is a power spectrum having both a ballistocardiogram spectrum, which is a power spectrum due to the ballistocardiogram of the living body, and a respiratory spectrum, which is a power spectrum due to the breathing of the living body.

10. The presence / absence determining device according to any one of claims 7 to 9, wherein the ballistocardiogram signal is acquired based on a representative value of the vital spectrum.

11. 11. The presence / absence determining device according to claim 10, wherein the representative value of the vital spectrum is any one of a maximum value, a minimum value, an average value, a median value, and a sum of the vital spectrum.

12. 12. The presence / absence determining device according to claim 7, wherein the piezoelectric sensor sheet is disposed under a cushion body on which the living body is placed.

13. 13. The presence / absence determining device according to claim 1, wherein the non-presence determining time is set within a range of 0.5 to 60 seconds.

14. The presence / absence determination device according to any one of claims 1 to 13, wherein the absence determination unit performs the absence determination by comparing a representative value of the ballistocardiogram signal within a predetermined time period with the absence threshold value.

15. The presence / absence determination device according to any one of claims 1 to 13, wherein the non-existence determination unit performs the non-existence determination by comparing any one of the maximum value, minimum value, average value, median value, and sum of the ballistocardiogram signal within a specified period of time with the non-existence threshold value.

16. The presence / absence determination device according to any one of claims 1 to 15, further comprising a signal amplifier for amplifying the ballistocardiographic signal.

17. The presence / absence determining device according to claim 16, further comprising a heartbeat waveform calculation unit that calculates a heartbeat waveform from the ballistocardiogram signal amplified by the signal amplification unit.

Citation Information

Patent Citations

  • Monitoring device

    JP1995204166A

  • Present-on-bed determination apparatus and sleep measurement apparatus

    JP2013146532A

  • Person presence / absence detection method and person presence / absence detection device

    JP2013210367A

  • Bed-leaving sensor and bed-leaving detection method

    JP2015008920A